Quantcast
Last updated on April 18, 2014 at 16:58 EDT

Latest pharmaceutical industry Stories

2014-03-31 12:29:39

LONDON, March 31, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: United States Pharmaceuticals and Healthcare Report Q1 2014 Includes 3 FREE quarterly updates BMI View:Despite the botched rollout of the Affordable Care Act, we expect reform of the US healthcaresystem to continue over the coming years, mainly due to the need to control growth in spending on medicalservices. Implementation will not be smooth due to the law's numerous opponents. We...

2014-03-31 08:28:28

More than half of biopharmaceutical companies surveyed use a Strategic Partnership model BOSTON, March 31, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today released Strategic Partnerships 2014: Driving Biopharmaceutical Outsourcing Effectiveness, at the 23rd Annual Partnerships in Clinical Trials Conference in Las Vegas, NV. It provides compelling insights that highlight the value of these multi-year, highly integrated...

2014-03-30 23:21:43

Texas Medicaid fraud attorney J. Mark Brewer says he hopes $27 million payments by Teva Pharmaceutical Industries Ltd. to resolve allegations of illegal payments to a doctor to prescribe certain drugs sends a strong message to other drug companies. Houston, TX (PRWEB) March 30, 2014 Teva Pharmaceutical Industries Ltd. recently agreed to pay the federal government and the State of Illinois $27.6 million to resolve allegations of illegally paying a doctor to prescribe certain dangerous...

2014-03-30 23:04:37

VGXI announced today that the corporation won the award for Best CMO at the 7th Annual ViE Awards Ceremony held at the 2014 World Vaccine Congress in Washington, D.C. The Woodland's, TX (PRWEB) March 30, 2014 For the second year in a row, VGXI, Inc. was awarded the title of Best Contract Manufacturing Organization (CMO) at the Annual ViE Awards Ceremony held at the World Vaccine Congress in Washington, D.C. on March 25, 2014. VGXI is a leading provider of DNA plasmid manufacturing...

2014-03-28 23:25:53

Verified Clinical Trials is proud to announce their presence at the Partnerships In Clinical Trials meeting in Las Vegas, Nevada to discuss the largest North American clinical research volunteer database that stops dual enrollment in clinical trials, while promoting patient safety and data quality. VCT is partnered with the world's largest pharmaceutical companies and CROs and continues to grow at an exponential pace in an effort to eliminate the professional research subject. Garden...

2014-03-28 23:25:00

Nevada case involves allegations that women developed cancer as a result of Actos medication. National network of attorneys is offering no-cost consultations to consumers seeking compensation over similar claims. San Diego, CA (PRWEB) March 28, 2014 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html Resource4thePeople today announced its latest update for consumers following litigation involving allegations that the use of Actos to treat diabetes can cause...

2014-03-28 23:24:53

The Device Software Verification and Validation webinar rebroadcast will give attendees a clear understanding of FDA inspector expectations and how to meet them, with a specific focus on software that is as-product, in-product, process and/or in overall manufacturing and operations. Why risk FDA sanctions, let alone multimillion-dollar liability lawsuits? Falls Church, VA (PRWEB) March 28, 2014 Device Software Verification and Validation: Get Ready for a New Breed of Investigators...

2014-03-28 16:22:54

DUBLIN, March 28, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States Court of Appeals for the Federal Circuit has reversed a lower court ruling that Actavis' generic version of Shire's Lialda(®) (mesalamine extended-release tablets) infringes United States Patent No. 6,773,720 (the '720 Patent). The Appeals Court found that the U.S. District Court for the Southern District of Florida did not correctly construe the claims of the '720 Patent, and...

2014-03-28 16:22:39

TAMPA, Fla., March 28, 2014 /PRNewswire-USNewswire/ -- Top officials from the US FDA will meet with ISPE Members and other pharmaceutical industry leaders to discuss compliance trends and identify practical solutions for modern quality systems, technology transfer, metrics implementation and other relevant topics during the third annual ISPE-FDA CGMP Conference, taking place 2 - 4 June in Baltimore, Md. USA. The conference will explore industry hot topics in an ongoing conversation between...

2014-03-28 12:26:46

Company Reports Phase III Trial Progress, Positive Regulatory and ASCO Decisions; BETHESDA, Md., March 28, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today refuted false and misleading claims by Adam Feuerstein in an article posted Thursday, March 27, after NW Bio's public presentation of significant positive news about all of the Company's programs....